通过编码IL-12的AZD4820型疫苗病毒介导抗瘤活性
Cheyne Kurokawa1, Sonia Agrawal2, Abhisek Mitra3
1Virology and Vaccine Discovery, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Molecular therapy. Oncology
|April 10, 2024
概括
工程设计的AZD4820型病毒表达介质蛋白-12 (IL-12) 来激活免疫细胞. 这种疗法对抗抗免疫检查点抑制剂耐药的瘤有希望,在临床前模型中显示出显著的抗瘤活性和完整的反应.
科学领域:
- 瘤治疗性病毒疗法
- 免疫治疗是一种免疫疗法.
- 癌症研究 癌症研究
背景情况:
- 瘤病毒选择性地向瘤细胞,显示出临床前景.
- 介质素-12 (IL-12) 是一种激素,激活免疫细胞并重编程瘤微环境.
研究的目的:
- 为了设计AZD4820,一种表达IL-12的疫苗病毒,以增强抗瘤免疫力.
- 评估AZD4820在临床前癌症模型中的疗效,特别是那些抵抗免疫检查点抑制的癌症.
主要方法:
- 在体外测试AZD4820在人类瘤细胞系上的瘤活性和IL-12表达.
- 在MC38和CT26瘤模型中使用小鼠IL-12替代病毒的体内研究.
- 评估干扰素 (IFN-γ) 水平和完整反应率.
- 用AZD4820和抗PD-L1抗体进行组合治疗.
主要成果:
- AZD4820在体外表现出广泛的抗瘤活性和IL-12表达.
- 小鼠IL-12代理病毒在耐药瘤模型中显示出显著的抗瘤活性.
- 与对照疫苗病毒 (VACV) - 流星酶相比,AZD4820治疗提高了IFN-γ的调节.
- 在CT26模型中,60%的小鼠接受了AZD4820替代品的治疗,而对照组的小鼠则为0%.
- 组合疗法增强了瘤特异性T细胞免疫力.
结论:
- 疫苗病毒释放的IL-12 (AZD4820) 具有强烈的色活性和免疫刺激.
- AZD4820在临床前模型中显示出有效性,该模型对免疫检查点封锁无反应.
- 结合AZD4820和免疫检查点抑制剂可以引起强大的抗瘤免疫力.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.4K
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
1.2K
相关概念视频
01:27Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
01:30Cancer Vaccines
360
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
360
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K